# NORGESTIMATE AND ETHINYL ESTRADIOL
> **ANDA201896** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2016-01-27
## Drug
- **FDA Application Number:** ANDA201896
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NORGESTIMATE AND ETHINYL ESTRADIOL
- **Generic name:** Ethinyl Estradiol
- **Active ingredients:** ETHINYL ESTRADIOL; NORGESTIMATE
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN
- **First approval:** 2016-01-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201896)
---
*MORVS · CC0 1.0*